Literature DB >> 29718028

Current guidelines for psoriasis treatment: a work in progress.

Nicole M Golbari1, Martina L Porter2, Alexa B Kimball2.   

Abstract

Psoriasis is a complex chronic autoimmune skin disease with multiple comorbidities that can have a considerable impact on quality of life (QoL). As therapeutic options evolve, physicians should look to treatment guidelines and consensus statements to keep their practice and management of psoriasis patients current with worldwide standards. This article reviews the most up-to-date general guidelines available for the management of psoriasis.

Entities:  

Mesh：

Year:  2018        PMID： 29718028

Source DB:  PubMed          Journal:  Cutis        ISSN： 0011-4162


  15 in total

Review 1.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

2.  A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab.

Authors:  Kristian Garn Du Jardin; Pepi Hurtado Lopez; Mette Lange; Rachael McCool; Silvia Maeso Naval; Sandra Quickert
Journal:  J Health Econ Outcomes Res       Date:  2020-07-24

3.  A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).

Authors:  Fanni Rencz; Ariel Z Mitev; Ákos Szabó; Zsuzsanna Beretzky; Adrienn K Poór; Péter Holló; Norbert Wikonkál; Miklós Sárdy; Sarolta Kárpáti; Andrea Szegedi; Éva Remenyik; Valentin Brodszky
Journal:  Qual Life Res       Date:  2021-03-08       Impact factor: 4.147

Review 4.  Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis.

Authors:  Tse-Hung Huang; Chwan-Fwu Lin; Ahmed Alalaiwe; Shih-Chun Yang; Jia-You Fang
Journal:  Int J Mol Sci       Date:  2019-05-24       Impact factor: 6.208

5.  Pharmacokinetics and Safety of Icotinib Hydrochloride Cream in Patients with Mild to Moderate Chronic Plaque Psoriasis: A Randomized Double-Blind Vehicle-Controlled Phase 1 Study.

Authors:  Lunfei Liu; Honggang Lou; Jiong Zhou; Ying Shen; Min Zheng; Zourong Ruan
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

6.  Effectiveness comparisons of acupuncture for psoriasis: A Bayesian network meta-analysis protocol.

Authors:  Zhi-Yin Xie; Yu Zhou; Sheng Deng; Wei Ding; Xing-Wu Duan; Li-Rong Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

7.  Autologous blood or autologous serum acupoint injection therapy for psoriasis vulgaris: A protocol for a systematic review and meta-analysis.

Authors:  Qiuyue Wang; Mao Li; Xingxin Hu; Qian Luo; Pingsheng Hao
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

8.  A Six-Year Analysis of Biological Therapy for Severe Psoriasis in a Lithuanian Reference Centre of Dermatovenereology.

Authors:  Tadas Raudonis; Akvile Gliebute; Anna Greta Grigaityte; Zivile Lukosiunaite; Tatjana Karmaziene; Jurate Grigaitiene
Journal:  Medicina (Kaunas)       Date:  2020-06-04       Impact factor: 2.430

Review 9.  Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.

Authors:  Salma A Fereig; Ghada M El-Zaafarany; Mona G Arafa; Mona M A Abdel-Mottaleb
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

10.  Effectiveness comparisons of traditional Chinese medicine for psoriasis: A Bayesian network meta-analysis.

Authors:  Longjun Wang; Yun Tao; Sheng Deng; Liyuan Chu; Linge Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.